Novel CD123 polyaptamer hydrogel edited by Cas9/sgRNA for AML-targeted therapy

CD123 targeting molecules have been widely applied in acute myelocytic leukemia (AML) therapeutics. Although antibodies have been more widely used as targeting molecules, aptamer have unique advantages for CD123 targeting therapy. In this study, we constructed an aptamer hydrogel termed as SSFH whic...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Drug Deliv
Autores principales: Wu, Haibin, Zhang, Liyu, Zhu, Zeen, Ding, Chenxi, Chen, Shengquan, Liu, Ruiping, Fan, Huafeng, Chen, Yang, Li, Hui
Formato: Artigo
Lenguaje:Inglês
Publicado: Taylor & Francis 2021
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8205012/
https://ncbi.nlm.nih.gov/pubmed/34121564
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10717544.2021.1934191
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares